NCT02009436View on ClinicalTrials.gov

Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 9, 2015

Primary Completion Date

July 18, 2018

Study Completion Date

July 18, 2018

Conditions
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Interventions
DRUG

Azacitidine

Given via nebulizer

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

Trial Locations (1)

10461

Albert Einstein College of Medicine, The Bronx

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Albert Einstein College of Medicine

OTHER

NCT02009436 - Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter